Xtant Medical

PRESS RELEASES

Home Investors PRESS RELEASES

PRESS RELEASES

Click here for Webcast
Xtant Medical Fourth Quarter 2023 Financial Results
 04/01/24  9:00 AM EDT

Keyword Search

Xtant Medical Receives Noncompliance Notice from NYSE American
April 5, 2019
BELGRADE, Mont. , April 05, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced receipt of notification from the NYSE American that the Company is not in
Read More
Xtant Medical Announces Fourth Quarter and 2018 Financial Results
April 1, 2019
BELGRADE, Mont. , April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended
Read More
Xtant Medical Announces Amendments and Extension of Credit Facility
April 1, 2019
BELGRADE, Mont. , April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has executed the Second Amended and Restated Credit Agreement
Read More
Xtant Medical Announces Appointment of New Senior Sales Leaders
February 12, 2019
BELGRADE, MT , Feb. 12, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the recent additions of five senior sales executives: Dana Lyons , Vice
Read More
Xtant Medical Announces Appointment of Chief Operations Officer
January 11, 2019
BELGRADE, MT , Jan. 11, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Ronald Berlin as Vice President & Chief Operations
Read More
Xtant Medical Announces Third Quarter 2018 Financial Results
November 14, 2018
BELGRADE, MT , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the third quarter ended September 30, 2018 .
Read More
Xtant Medical to Issue Third Quarter 2018 Results on November 14, 2018
November 12, 2018
BELGRADE, MT , Nov. 12, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the quarter and year to date ended September 30,
Read More
Xtant Medical Announces Appointment of Interim CEO
October 15, 2018
BELGRADE, MT , Oct. 15, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Michael Mainelli to serve as Interim Chief Executive
Read More